Predictive factors of the presence of pulmonary embolism in patients with interstitial lung disease: Observational study

被引:1
|
作者
Shimoda, Masafumi [1 ,2 ,3 ]
Nunokawa, Hiroki [2 ]
Tanaka, Yoshiaki [1 ]
Morimoto, Kozo [1 ]
Moue, Iori [1 ,2 ]
Yoshimori, Kozo [1 ]
Saraya, Takeshi [2 ]
Ohta, Ken [1 ]
Ishii, Haruyuki [2 ]
机构
[1] Japan Anti TB Assoc JATA, Fukujuji Hosp, Resp Dis Ctr, Kiyose, Tokyo, Japan
[2] Kyorin Univ, Fac Med, Dept Resp Med, Mitaka, Tokyo, Japan
[3] Japan AntiTB Assoc JATA, Fukujuji Hosp, Resp Dis Ctr, 3-1-24 Mastuyama, Kiyose, Tokyo 2048522, Japan
关键词
acute exacerbation; D-dimer; interstitial lung disease; pulmonary embolism; total protein; ASSESSING CLINICAL PROBABILITY; ACUTE EXACERBATION; FIBROSIS; THROMBIN; SCORE; RISK;
D O I
10.1097/MD.0000000000036828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with interstitial lung disease (ILD), the risk of pulmonary embolism (PE) is increased; however, distinguishing between PE and ILD exacerbation can be difficult. Therefore, this study investigated the usefulness of the Wells criteria and revised Geneva score and predictive factors for diagnosing PE in ILD patients with worsening respiratory symptoms. We retrospectively collected the data of 65 patients with ILD who underwent computed tomography pulmonary angiography at Fukujuji Hospital and Kyorin University Faculty of Medicine from January 2018 to March 2023, including 18 patients in the PE group and 47 patients in the non-PE group, and the data were compared between the 2 groups. The Wells score (P = .165) and revised Geneva score (P = .140) were not useful for distinguishing between the PE and non-PE groups. Patients in the PE group showed higher D-dimer, total protein (TP), and globulin levels than those in the non-PE group (D-dimer median 24.5 mu g/mL [range 3.0-79.3] vs 9.3 mu g/mL [range 0.5-80.8], P = .016; TP median 7.2 g/dL [range 5.1-8.7] vs 6.4 g/dL [range 5.0-8.2], P = .002; globulin median 3.8 g/dL [range 2.6-5.5] vs 3.2 g/dL [range 3.0-5.3], P = .041). Using cutoff values of TP >= 7.0 g/dL and D-dimer >= 11.8 mu g/mL, the odds ratios for predicting PE were 10.5 and 4.90, respectively. This study demonstrates that high TP and D-dimer levels are useful indicators for predicting PE in ILD patients with worsening respiratory symptoms, while the Wells score and revised Geneva score are not reliable in diagnosing PE.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
    Hunninghake, Gary M.
    Quesada-Arias, Luisa D.
    Carmichael, Nikkola E.
    Manzano, Jose M. Martinez
    De Frias, Sergio Poli
    Baumgartner, Maura Alvarez
    DiGianni, Lisa
    Gampala-Sagar, Shannon N.
    Leone, Dominick A.
    Gulati, Swati
    El-Chemaly, Souheil
    Goldberg, Hilary J.
    Putman, Rachel K.
    Hatabu, Hiroto
    Raby, Benjamin A.
    Rosas, Ivan O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (10) : 1240 - 1248
  • [22] Predictive factors for severe radiation-induced lung injury in patients with lung cancer and coexisting interstitial lung disease
    Park, Shin-Hyung
    Lim, Jae-Kwang
    Kang, Min Kyu
    Park, Jongmoo
    Hong, Chae Moon
    Kim, Chang Ho
    Cha, Seung Ick
    Lee, Jaehee
    Lee, Seoung-Jun
    Kim, Jae-Chul
    RADIOTHERAPY AND ONCOLOGY, 2024, 192
  • [23] Patients profile and pulmonary rehabilitation in interstitial lung disease
    Godmaire, Genevieve Courteau
    Lalande-Gauthier, Melina
    Dube, Bruno-Pierre
    Morisset, Julie
    Poirier, Claude
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
    Hunninghake, G. M.
    Quesada-Arias, L.
    Carmichael, N.
    Manzano, J. Martinez
    De Frias, S. Poli
    Baumgartner, M. Alvarez
    DiGianni, L.
    Gampala-Sagar, S.
    Leone, D.
    El-Chemaly, S. Y.
    Goldberg, H. J.
    Putman, R. K.
    Hatabu, H.
    Raby, B. A.
    Rosas, I. O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer
    Mizuno, Satoko
    Takiguchi, Yuichi
    Fujikawa, Ayako
    Motoori, Ken
    Tada, Yuji
    Kurosu, Katsushi
    Sekine, Yasuo
    Yanagawa, Noriyuki
    Hiroshima, Kenzo
    Muraoka, Katsumi
    Mitsushima, Toru
    Niki, Noboru
    Tanabe, Nobuhiro
    Tatsumi, Koichiro
    Kuriyama, Takayuki
    RESPIROLOGY, 2009, 14 (03) : 377 - 383
  • [26] Predictors of Pulmonary Hypertension in Patients With Interstitial Lung Disease
    Pannu, G.
    Pritchard, D.
    Sood, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [27] An observational study of clinical recurrence in patients with interstitial lung disease related to the antisynthetase syndrome
    Haoran Chen
    Huarui Liu
    Wenting Lyu
    Yin Liu
    Mei Huang
    Yingwei Zhang
    Yuying Qiu
    Yonglong Xiao
    Hourong Cai
    Jinghong Dai
    Clinical Rheumatology, 2023, 42 : 711 - 720
  • [28] An observational study of clinical recurrence in patients with interstitial lung disease related to the antisynthetase syndrome
    Chen, Haoran
    Liu, Huarui
    Lyu, Wenting
    Liu, Yin
    Huang, Mei
    Zhang, Yingwei
    Qiu, Yuying
    Xiao, Yonglong
    Cai, Hourong
    Dai, Jinghong
    CLINICAL RHEUMATOLOGY, 2023, 42 (03) : 711 - 720
  • [29] Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
    Y. Xu
    C. S. Yang
    Y. J. Li
    X. D. Liu
    J. N. Wang
    Q. Zhao
    W. G. Xiao
    P. T. Yang
    Clinical Rheumatology, 2016, 35 : 113 - 116
  • [30] Predictive factors for the long-term use of pirfenidone in patients with fibrosing interstitial lung disease
    Katano, Takuma
    Sekine, Akimasa
    Ikeda, Satoshi
    Yamakawa, Hideaki
    Misumi, Toshihiro
    Okabayashi, Hiroko
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Hagiwara, Eri
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2021, 59 (04) : 414 - 420